Versant Venture Capital VI, L.P. - Jun 22, 2021 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
10%+ Owner
Signature
By: /s/ Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: Robin L. Praeger Its: Managing Director
Stock symbol
IPSC
Transactions as of
Jun 22, 2021
Transactions value $
$2,000,000
Form type
4
Date filed
6/23/2021, 04:30 PM
Previous filing
Jun 17, 2021
Next filing
Jun 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Conversion of derivative security +9.94M +333.33% 12.9M Jun 22, 2021 Direct F1, F2
transaction IPSC Common Stock Conversion of derivative security +614K 614K Jun 22, 2021 See footnote F3, F4
transaction IPSC Common Stock Purchase $2M +100K +16.28% $20.00* 714K Jun 22, 2021 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Series A Preferred Stock Conversion of derivative security $0 -25M -100% $0.00* 0 Jun 22, 2021 Common Stock 9.94M Direct F1, F2
transaction IPSC Series C Preferred Stock Conversion of derivative security $0 -1.55M -100% $0.00* 0 Jun 22, 2021 Common Stock 614K See footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
F2 The reportable securities are owned directly by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.
F3 Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
F4 The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein.